Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,728 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency.
Zafeiriou Z, Bianchini D, Chandler R, Rescigno P, Yuan W, Carreira S, Barrero M, Petremolo A, Miranda S, Riisnaes R, Rodrigues DN, Gurel B, Sumanasuriya S, Paschalis A, Sharp A, Mateo J, Tunariu N, Chinnaiyan AM, Pritchard CC, Kelly K, de Bono JS. Zafeiriou Z, et al. Among authors: kelly k. Eur Urol. 2019 Jan;75(1):184-192. doi: 10.1016/j.eururo.2018.09.048. Epub 2018 Oct 16. Eur Urol. 2019. PMID: 30340782 Free PMC article.
Assessment of hormone refractory prostate cancer.
Newling D, Fosså SD, Andersson L, Abrahamsson PA, Aso Y, Eisenberger MA, Khoury S, Kozlowski JS, Kelly K, Scher H, Hartley-Asp B. Newling D, et al. Among authors: kelly k. Urology. 1997 Apr;49(4A Suppl):46-53. doi: 10.1016/s0090-4295(99)80323-9. Urology. 1997. PMID: 9111614 Free article.
Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer.
Slovin SF, Knudsen K, Halabi S, de Leeuw R, Shafi A, Kang P, Wolf S, Luo B, Gopalan A, Curley T, Fleming M, Molina A, Fernandez C, Kelly K. Slovin SF, et al. Among authors: kelly k. J Clin Oncol. 2023 Nov 10;41(32):5015-5024. doi: 10.1200/JCO.22.02639. Epub 2023 Aug 15. J Clin Oncol. 2023. PMID: 37582240 Clinical Trial.
A MEF2C transcription factor network regulates proliferation of glomerular endothelial cells in diabetic kidney disease.
Ferreira RM, Gisch DL, Phillips CL, Cheng YH, Asthana M, Lake BB, Bowen WS, Fang F, Asghari M, Sabo A, Barwinska D, Ferkowicz MJ, Toto RD, Sedor JR, Rosas SE, Bjornstad P, Hodgin JB, Alpers CE, Sarder P, Himmelfarb J, Schaub JA, Nair V, Winfree S, Sutton TA, Kelly KJ; Kidney Precision Medicine Project; Kretzler M, Jain S, El-Achkar TM, Dagher PC, Eadon MT. Ferreira RM, et al. Among authors: kelly kj. bioRxiv [Preprint]. 2024 Dec 31:2024.09.27.615250. doi: 10.1101/2024.09.27.615250. bioRxiv. 2024. PMID: 39803522 Free PMC article. Preprint.
State of Lung Cancer in Egypt: Moving Towards Improved Guidelines for Prevention, Screening, Treatment, and Clinical Care Programs.
Karim NA, Rabea AM, Mack PC, Subramanian J, Khalil E, Sherif M, Marawan R, Gaafar T, Shash L, Suzuki K, Ahluwalia M, Wahba H, Aboelela S, Al Ahmadi A, Al Husaini H, Mohsen N, Khaled R, Kassem N, Khaled H, El Said N, Zakhary N, Shoukry D, ElSadieque AA, Alsedfy MY, Islam S, ElSherbiny H, El Deftar M, Awad N, Mohamed AR, Gandara D, Kelly K, Sen T. Karim NA, et al. Among authors: kelly k. JTO Clin Res Rep. 2024 Nov 21;6(1):100776. doi: 10.1016/j.jtocrr.2024.100776. eCollection 2025 Jan. JTO Clin Res Rep. 2024. PMID: 39790369 Free PMC article.
Glucarpidase for Treatment of High-Dose Methotrexate Toxicity.
Gupta S, Kaunfer SA, Chen KL, Dias JA, Vijayan A, Rajasekaran A, Prosek J, Truong HL, Wood A, Bassil C, Renaghan AD, Shah CV, Zhang J, Glezerman I, Carlos C, Kelly K, Passero CJ, Drappatz J, Abudayyeh A, Shin D, Sperati CJ, Yelvington BJ, Kanduri SR, Neyra JA, Edmonston D, Shirali AC, Bansal A, Geara A, Mithani Z, Ziolkowski SL, Rashidi A, Jakubowski J, Pujari A, Bond DA, Dotson EK, Wall SA, Patton JT, Barreto JN, Herrmann SM, Sheikh MS, Baz RC, Lee JH, Lucchesi N, Kolman M, Rasheed MA, Afzal A, Kang D, Mahesh A, Hsu R, Nicolaysen A, Tefera K, Schretlen C, Miller RM, Velez JCQ, Flannery AH, Aklilu AM, Anand S, Chandrasekhara S, Donley V, Patel A, Ni J, Krishnamurthy S, Ali R, Yilmam OA, Wells SL, Ortega JL, Green-Lingren OL, Leaf RK, Sise ME, Nayak L, LaCasce AS, Leung N, Leaf DE. Gupta S, et al. Among authors: kelly k. Blood. 2025 Jan 6:blood.2024026211. doi: 10.1182/blood.2024026211. Online ahead of print. Blood. 2025. PMID: 39760780
Estimating the Risk of Cardiovascular Events in U.S. Veterans Using the SMART Risk Score.
Banerjee S, Weideman RA, Jacob DA, DiGregorio HR, Kelly KC, Banerjee A, Ravishankar M, Strickland PT, Abraham HM, Minniefield NE, Grimsley BR, Schussler JM, Parmar RJ, Stoler RC, Brilakis ES, Little BB. Banerjee S, et al. Among authors: kelly kc. JACC Adv. 2024 Dec 12;4(1):101459. doi: 10.1016/j.jacadv.2024.101459. eCollection 2025 Jan. JACC Adv. 2024. PMID: 39759440 Free PMC article.
Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical Trial.
Daw S, Cole PD, Hoppe BS, Hodgson D, Beishuizen A, Garnier N, Buffardi S, Mascarin M, Lissat A, Mauz-Körholz C, Krajewski J, Akyol A, Crowe R, Anderson B, Xu Y, Drachtman RA, Kelly KM, Leblanc T, Harker-Murray P. Daw S, et al. Among authors: kelly km. JAMA Oncol. 2025 Jan 2. doi: 10.1001/jamaoncol.2024.5627. Online ahead of print. JAMA Oncol. 2025. PMID: 39745739
3,728 results